Molecular simulation of zwitterionic polypeptides on protecting glucagon-like peptide-1 (GLP-1)

Int J Biol Macromol. 2021 Mar 31:174:519-526. doi: 10.1016/j.ijbiomac.2021.01.207. Epub 2021 Feb 1.

Abstract

Owing to their anti-fouling properties, zwitterionic polypeptides demonstrate great advantage on protecting protein drugs. When conjugated to glucagon-like peptide-1 (GLP-1), a drug for type-II diabetes, zwitterionic polypeptides confer better pharmacokinetics than uncharged counterparts. However, its microscopic mechanism is still unclear due to the complicated conformational space. To address this challenge, this work explored the interaction modes of GLP-1 with the unconnected repeat units, instead of the full-length polypeptides. The three repeat units are two zwitterionic pentapeptides VPKEG and VPREG, and one uncharged control VPGAG. Our molecular simulations revealed that the helical conformation of GLP-1 was stabilized by adding 40 polypeptides. Both VPGAG and VPREG formed dense packing shells around GLP-1, but the driving forces were hydrophobic and electrostatic interactions, respectively. In contrast, the packing shell composed of VPKEG was most loose, while could still stabilize GLP-1. The moderate electrostatic interactions endowed VPKEG an anti-fouling property, thereby avoiding non-specific interaction with other amino acids. The strong electrostatic interactions exerted by arginine promoted atomic contacts between VPREG and other residues, making it as "hydrophobic" as VPGAG. In summary, the combination of hydrophobic and moderate electrostatic interactions in VPKEG brings about a subtle balance between stabilizing GLP-1 and avoiding non-specific interaction.

Keywords: GLP-1; Molecular simulation; Zwitterionic polypeptides.

MeSH terms

  • Animals
  • Drug Stability
  • Glucagon-Like Peptide 1 / chemistry
  • Glucagon-Like Peptide 1 / pharmacokinetics*
  • Humans
  • Hydrophobic and Hydrophilic Interactions
  • Molecular Dynamics Simulation
  • Peptides / chemistry*
  • Protein Structure, Secondary

Substances

  • Peptides
  • Glucagon-Like Peptide 1